Press releases
Theravance Biopharma, Inc. to Host Virtual Key Opinion Leader (KOL) Event to Discuss Ampreloxetine's Potential for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension (nOH) in Patients with Multiple System Atrophy (MSA) on May 23, 2024
10 Apr 24
Press Releases
Theravance Biopharma to Participate in an Upcoming Investor Conference
22 Feb 24
Press Releases
Theravance Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024
14 Feb 24
Press Releases